Interestingly, while the upregulation in tumors is markedly higher for CCL4 and CXCL2, the CCL2, CCL8 and CCL19 transcripts are relatively downregulated in tumors compared to tumor-adjacent tissue. The gene discussed is CXCL2; the disease is neoplasm.